|
|
 |
OSCO NEWS |
|
   |
|
Jan 26, '10
|
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain - The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.
read more
|
   |
|
Jan 21, '10
|
|
   |
|
Sep 22, '09
|
|
   |
|
Sep 16, '09
|
FDA Clears a Test for Ovarian Cancer - FDA Clears a Test for Ovarian Cancer
Test can help identify potential malignancies, guide surgical decisions
The U.S. Food and Drug Administration today cleared a test that can help detect ovarian cancer in a pelvic mass that is already known to require surgery. The test, called OVA1, helps patients and health care professionals decide what type of surgery should be done and by whom.
read more
|
   |
|
Sep 16, '09
|
FDA Requires Boxed Warning for Promethazine Hydrochloride Injection - FDA Requires Boxed Warning for Promethazine Hydrochloride Injection
The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDA's authority to require safety labeling changes, will highlight the risk of serious tissue injury when this drug is administered incorrectly. The agency is also alerting health care professionals to the new boxed warning for this product, which is used as a sedative and to treat nausea and vomiting.
read more
|
   |
|
Aug 21, '09
|
|
   |
|
Aug 21, '09
|
Reporting Non-Tax Withholding Due to Federal Payment Levy Program (FPLP) - Reporting Non-Tax Withholding Due to Federal Payment Levy Program (FPLP)
Reference: Trans. 503, CR #6228, Pub. 100-20, MLN: MM6228
Published Online: 8/14/2009
Provider Types Affected
Physicians and providers who bill Medicare carriers, fiscal intermediaries (FI), and Medicare Administrative Contractors (MAC) for services provided to Medicare beneficiaries.
read more
|
   |
|
Aug 21, '09
|
New Rx for Health Plan: Split Bill - By JONATHAN WEISMAN and NAFTALI BENDAVID
The White House and Senate Democratic leaders, seeing little chance of bipartisan support for their health-care overhaul, are considering a strategy shift that would break the legislation into two parts and pass the most expensive provisions solely with Democratic votes
read more
|
   |
|
Aug 07, '09
|
|
   |
|
Jul 31, '09
|
FDA Approval for Avastin in Combination with Interferon Alfa - Bevacizumab (Avastin) in Combination with Interferon Alfa
On July 31, 2009 the U.S. Food and Drug Administration granted approval for the use of bevacizumab (Avastin, Genentech, Inc.) in combination with interferon alfa for the treatment of patients with metastatic renal cell carcinoma. The approval was based on results from the BO17705 trial which demonstrated a 5 month improvement in median progression-free survival (PFS) in bevacizumab-treated patients.
read more
Related Website: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125085s0168lbl.pdf |
   |
| |
|